Literature DB >> 19089608

Lack of association between retrospectively collected pharmacy refill data and electronic drug monitoring of antiretroviral adherence.

Trisha Acri1, Thomas R TenHave, Jennifer C Chapman, Hillary R Bogner, Robert Gross.   

Abstract

Antiretroviral medication refill adherence has not been compared directly to electronic drug monitoring (EDM) in any identifiable published study. We retrospectively studied adults with undetectable HIV titers on highly active antiretroviral therapy. We used Pearson correlation coefficients and receiver operating characteristic curves to relate the two adherence measures, and we used the Wilcoxon rank-sum test to assess the relation between adherence and viral load. In sixty-five subjects, the majority of whom were African American and male with median age of 44 years, pharmacy refill adherence was difficult to collect retrospectively, was not significantly correlated with EDM adherence, and was not significantly related to viral load. Ninety-day supply pharmacy refill adherence correctly classified 95% EDM adherence maximally at 94 days between refills, and the measure was most sensitive for non-adherence at <90 days. Reassessment of the relation between pharmacy refill data and EDM would be warranted when pharmacy refill data is collected as soon as feasible from sources with complete data capture.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19089608      PMCID: PMC2891597          DOI: 10.1007/s10461-008-9502-1

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  30 in total

1.  Effect of adherence to newly initiated antiretroviral therapy on plasma viral load.

Authors:  R Gross; W B Bilker; H M Friedman; B L Strom
Journal:  AIDS       Date:  2001-11-09       Impact factor: 4.177

2.  Non-adherence to highly active antiretroviral therapy predicts progression to AIDS.

Authors:  D R Bangsberg; S Perry; E D Charlebois; R A Clark; M Roberston; A R Zolopa; A Moss
Journal:  AIDS       Date:  2001-06-15       Impact factor: 4.177

Review 3.  Measuring adherence to antiretroviral medications in clinical trials.

Authors:  L G Miller; R D Hays
Journal:  HIV Clin Trials       Date:  2000 Jul-Aug

4.  Patterns of adherence to antiretroviral medications: the value of electronic monitoring.

Authors:  JoCarol J McNabb; David P Nicolau; Julie A Stoner; Jack Ross
Journal:  AIDS       Date:  2003-08-15       Impact factor: 4.177

5.  Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.

Authors:  D R Bangsberg; F M Hecht; E D Charlebois; A R Zolopa; M Holodniy; L Sheiner; J D Bamberger; M A Chesney; A Moss
Journal:  AIDS       Date:  2000-03-10       Impact factor: 4.177

6.  Provider assessment of adherence to HIV antiretroviral therapy.

Authors:  D R Bangsberg; F M Hecht; H Clague; E D Charlebois; D Ciccarone; M Chesney; A Moss
Journal:  J Acquir Immune Defic Syndr       Date:  2001-04-15       Impact factor: 3.731

7.  Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients.

Authors:  Patricia García de Olalla; Hernando Knobel; Alexia Carmona; Ana Guelar; José L López-Colomés; Joan A Caylà
Journal:  J Acquir Immune Defic Syndr       Date:  2002-05-01       Impact factor: 3.731

8.  How long is the window of opportunity between adherence failure and virologic failure on efavirenz-based HAART?

Authors:  Robert Gross; Warren B Bilker; Hao Wang; Jennifer Chapman
Journal:  HIV Clin Trials       Date:  2008 May-Jun

9.  Provider inaccuracy in assessing adherence and outcomes with newly initiated antiretroviral therapy.

Authors:  Robert Gross; Warren B Bilker; Harvey M Friedman; James C Coyne; Brian L Strom
Journal:  AIDS       Date:  2002-09-06       Impact factor: 4.177

10.  How well do clinicians estimate patients' adherence to combination antiretroviral therapy?

Authors:  Loren G Miller; Honghu Liu; Ron D Hays; Carol E Golin; C Keith Beck; Steven M Asch; Yingying Ma; Andrew H Kaplan; Neil S Wenger
Journal:  J Gen Intern Med       Date:  2002-01       Impact factor: 5.128

View more
  8 in total

Review 1.  A proposal for quality standards for measuring medication adherence in research.

Authors:  Ann Bartley Williams; K Rivet Amico; Carol Bova; Julie A Womack
Journal:  AIDS Behav       Date:  2013-01

2.  How long is the right interval for assessing antiretroviral pharmacy refill adherence?

Authors:  Trisha L Acri; Robert M Grossberg; Robert Gross
Journal:  J Acquir Immune Defic Syndr       Date:  2010-08       Impact factor: 3.731

3.  Antidepressant treatment and adherence to antiretroviral medications among privately insured persons with HIV/AIDS.

Authors:  Ayse Akincigil; Ira B Wilson; James T Walkup; Michele J Siegel; Cecilia Huang; Stephen Crystal
Journal:  AIDS Behav       Date:  2011-11

4.  Association between medication possession ratio, virologic failure and drug resistance in HIV-1-infected adults on antiretroviral therapy in Côte d'Ivoire.

Authors:  Eugène Messou; Marie-Laure Chaix; Delphine Gabillard; Albert Minga; Elena Losina; Vincent Yapo; Martial Kouakou; Christine Danel; Caroline Sloan; Christine Rouzioux; Kenneth A Freedberg; Xavier Anglaret
Journal:  J Acquir Immune Defic Syndr       Date:  2011-04       Impact factor: 3.731

Review 5.  Point-of-care and Near Real-time Testing for Antiretroviral Adherence Monitoring to HIV Treatment and Prevention.

Authors:  Paul K Drain; Ashley R Bardon; Jane M Simoni; Tim R Cressey; Pete Anderson; Derin Sevenler; Ayokunle O Olanrewaju; Monica Gandhi; Connie Celum
Journal:  Curr HIV/AIDS Rep       Date:  2020-10       Impact factor: 5.071

6.  Second-line antiretroviral therapy: long-term outcomes in South Africa.

Authors:  Richard A Murphy; Henry Sunpath; Carmen Castilla; Shameez Ebrahim; Richard Court; Hoang Nguyen; Daniel Kuritzkes; Vincent C Marconi; Jean B Nachega
Journal:  J Acquir Immune Defic Syndr       Date:  2012-10-01       Impact factor: 3.731

7.  Simplifying TREAtment and Monitoring for HIV (STREAM HIV): protocol for a randomised controlled trial of point-of-care urine tenofovir and viral load testing to improve HIV outcomes.

Authors:  Ashley R Bardon; Jienchi Dorward; Yukteshwar Sookrajh; Fathima Sayed; Justice Quame-Amaglo; Cheryl Pillay; Erika Feutz; Hope Ngobese; Jane M Simoni; Monisha Sharma; Tim R Cressey; Monica Gandhi; Richard Lessells; Pravi Moodley; Nivashnee Naicker; Kogieleum Naidoo; Katherine Thomas; Connie Celum; Salim Abdool Karim; Nigel Garrett; Paul K Drain
Journal:  BMJ Open       Date:  2021-10-05       Impact factor: 3.006

8.  Pharmacy refill adherence outperforms self-reported methods in predicting HIV therapy outcome in resource-limited settings.

Authors:  Raphael Z Sangeda; Fausta Mosha; Mattia Prosperi; Said Aboud; Jurgen Vercauteren; Ricardo J Camacho; Eligius F Lyamuya; Eric Van Wijngaerden; Anne-Mieke Vandamme
Journal:  BMC Public Health       Date:  2014-10-04       Impact factor: 3.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.